(4R,5S,6S)-3-(((3S,5S)-1-((2S,3R)-2-((2S,3R)-5-carboxylato-4-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-3-methyl-2,3-dihydro-1H-pyrrol-2-yl)-3-hydroxybutanoyl)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate and (4R,5S,6S)-3-(((3S,5S)-1-((2S,3R)-2-((2S,3R)-5-carboxylato-4-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-3-methyl-3,4-dihydro-2H-pyrrol-2-yl)-3-hydroxybutanoyl)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate, sodium salt (1:2)
Meropenem EP Impurity B Disodium Salt is a fully characterized chemical compound used as a reference standard of API Meropenem. The standard offered is compliant with regulatory guidelines. Meropenem EP Impurity B Disodium Salt is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
Meropenem EP Impurity A Sodium Salt
M.F.
M.W. 400.48 22.99
CAT# AR-M04227
CAS# 1053703-36-8 (free acid)
